Cleared Traditional

K171566 - Atellica IM High-Sensitivity Troponin I (TNIH) (FDA 510(k) Clearance)

Jul 2018
Decision
415d
Days
Class 2
Risk

K171566 is an FDA 510(k) clearance for the Atellica IM High-Sensitivity Troponin I (TNIH). This device is classified as a Immunoassay Method, Troponin Subunit (Class II - Special Controls, product code MMI).

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on July 19, 2018, 415 days after receiving the submission on May 30, 2017.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1215.

Submission Details

510(k) Number K171566 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2017
Decision Date July 19, 2018
Days to Decision 415 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code MMI — Immunoassay Method, Troponin Subunit
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1215

Similar Devices — MMI Immunoassay Method, Troponin Subunit

All 7
VITROS Immunodiagnostic Products hs Troponin I Reagent Pack
K252393 · Ortho-Clinical Diagnostics, Inc. · Oct 2025
Access hsTnI
K243483 · Beckman Coulter, Inc. · Aug 2025
Access hsTnI
K242870 · Beckman Coulter, Inc. · Jun 2025
Atellica® IM High-Sensitivity Troponin I (TnIH)
K241165 · Siemens Healthcare Diagnostics, Inc. · Jul 2024
Access hsTnI
K222881 · Beckman Coulter, Inc. · Dec 2023
Access hsTnI
K230648 · Beckman Coulter, Inc. · Dec 2023